查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1866371

全球快速诊断试剂盒市场－2025-2030年预测

Global Rapid Diagnostic Kits Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球快速诊断试剂盒市场预计将从 2025 年的 254.7 亿美元成长到 2030 年的 360.83 亿美元，复合年增长率为 7.22%。

快速诊断试剂盒能够快速提供初步的医疗结果，从而以最少的资源实现及时治疗。这些试剂盒设计简便，即使是医学知识有限的人也能轻鬆使用，对于疾病的早期发现至关重要。心血管疾病（CVD）和糖尿病等慢性疾病的日益流行，以及人们对早期疗育意识的不断提高，推动了市场的发展。技术进步提高了试剂盒的可用性和功能，促进了市场成长。然而，结果不准确、需要显微镜检查才能确诊以及一次性试纸等耗材的高昂成本等限制因素，限制了市场扩张。

市场驱动因素

慢性病发生率呈上升趋势

心血管疾病和糖尿病发病率的不断上升显着推动了对快速诊断试剂盒，尤其是心血管代谢检测套组的需求。心血管疾病仍然是全球主要的死亡原因之一，而心臟病和中风通常可以透过早期发现来预防。糖尿病是另一个主要的健康问题，需要定期监测，这推动了对血糖监测试剂盒的需求。高血压和高血脂症等相关疾病的快速增长进一步推动了对能够及时干预的诊断工具的需求，从而促进了市场成长。

提高对预防性护理的认识和获得预防性护理的机会

预防保健意识的日益增强，尤其是在已开发地区，正推动快速诊断试剂盒的普及。这些试剂盒满足了注重健康的消费者对便利快速血糖值监测、药物使用检测等解决方案的需求。妊娠测试和药物滥用检测套组的日益普及也透过提供快速检测结果促进了市场扩张。然而，家用检测套组和虚拟报告服务等竞争性诊断解决方案的存在，为市场带来了挑战，限制了快速诊断试剂盒的应用范围。

市场限制

快速诊断试剂盒的准确性是其主要阻碍因素。假阳性或假阴性结果需要显微镜检查确认，这降低了其自身的可靠性。耗材（例如血糖值试纸）的高成本和电池容量限制也推高了营运成本，尤其是在中低收入地区，这些地区的民众对相关知识的认知度和购买力都较低。此外，其他诊断技术的进步，提供了更准确、更全面的解决方案，进一步限制了其市场前景。

市场区隔分析

依应用领域划分，该市场可细分为血糖监测、心血管代谢检测、传染病检查、药物滥用检测、不孕症及怀孕检测等。由于心血管疾病 (CVD) 和糖尿病的盛行率不断上升，预计心血管代谢检测套组将显着增长。血糖监测仪是糖尿病管理的必备设备，而药物滥用检测套组和妊娠检测套组则因其易用性和快速出结果而备受关注。依通路，该市场涵盖多种管道，便利的获取途径正在推动各细分市场的普及。

区域展望

北美预计将引领快速诊断试剂盒市场，这主要得益于该地区疾病高发、医疗基础设施完善以及广泛的宣传活动。美国心臟协会 (AHA) 和美国医学会 (AMA) 等机构正在积极推广预防性医疗保健，推动了试剂盒的普及。同时，亚太地区预计将迎来最高的成长率，这主要受心血管疾病 (CVD)、糖尿病和癌症等非传染性疾病 (NCD) 发病率上升的推动。政府加大医疗保健投入和意识提升的提高将促进市场扩张，但部分地区的高成本和低普及率仍然是挑战。

由于慢性病发病率上升以及对便捷易用的诊断工具的需求不断增长，快速诊断试剂盒市场预计将持续成长。心血管代谢疾病和血糖监测试剂盒因其在疾病管理中的重要性而占据主导地位。北美将占据最大的市场份额，而亚太地区预计将快速成长。儘管技术不断进步，但准确性问题、高成本以及其他诊断方法的竞争限制了其发展潜力。产业相关人员需要努力提高试剂盒的可靠性和降低成本，以掌握全球健康趋势带来的机会。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

5. 全球快速诊断试剂盒市场（依技术划分）

  • 介绍
  • 横向流动化验
  • 凝血法
  • 其他的

6. 全球快速诊断试剂盒市场（按应用划分）

  • 介绍
  • 血糖监测
  • 心血管代谢检测
  • 传染病检查
  • 药物滥用检测
  • 不孕症治疗和妊娠测试
  • 其他的

7. 全球快速诊断试剂盒市场（依最终用户划分）

  • 介绍
  • 医院和诊所
  • 诊断中心
  • 其他的

8. 全球快速诊断试剂盒市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 台湾
    • 其他的

第九章：竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Creative Diagnostics
  • Abbott Laboratories
  • NanoRepro AG
  • Atlas Medical UK
  • Coris BioConcept
  • Roche Diagnostics
  • SD Biosensor
  • ACON Laboratories Inc.
  • Alfa Scientific Designs Inc.
  • AdvaCare Pharma

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061612022

The Global Rapid Diagnostic Kits Market is set to expand from USD 25.470 billion in 2025 to USD 36.083 billion by 2030, at a CAGR of 7.22%.

Rapid diagnostic kits deliver quick, preliminary medical results, enabling timely treatment with minimal resources. Designed for ease of use by individuals with limited medical expertise, these kits are vital for early disease detection. The market is driven by the rising prevalence of chronic diseases like cardiovascular diseases (CVD) and diabetes, coupled with growing awareness of early intervention. Technological advancements enhance kit accessibility and functionality, fostering market growth. However, limitations such as inaccurate results, the need for confirmatory microscopic tests, and high recurring costs of consumables like disposable strips restrain expansion.

Market Drivers

Rising Prevalence of Chronic Diseases

The increasing incidence of cardiovascular diseases and diabetes significantly propels the demand for rapid diagnostic kits, particularly cardiometabolic testing kits. CVD remains a leading global cause of mortality, with heart attacks and strokes often preventable through early detection. Diabetes, another major health concern, necessitates regular monitoring, boosting the demand for glucose monitoring kits. The surge in related conditions like hypertension and hyperlipidemia further drives the need for diagnostic tools to facilitate timely interventions, supporting market growth.

Growing Awareness and Accessibility

Increased awareness of preventive healthcare, especially in developed regions, encourages the adoption of rapid diagnostic kits. These kits cater to health-conscious consumers seeking convenient, fast solutions for monitoring conditions like blood glucose or drug use. The accessibility of kits for pregnancy and drug-of-abuse testing, offering quick results, also contributes to market expansion. However, the market faces challenges from competing diagnostic solutions, such as home testing and virtual reporting services, which limit the scope of rapid kits.

Market Restraints

The accuracy of rapid diagnostic kits is a significant limitation, as false-positive or false-negative results necessitate confirmatory microscopic tests, reducing their standalone reliability. High costs of consumables, such as glucose monitor strips, and battery limitations add to operational expenses, particularly in low- and middle-income regions where awareness and affordability are lower. Advancements in alternative diagnostic technologies further constrain market prospects by offering more precise or comprehensive solutions.

Market Segment Analysis

The market is segmented by application into glucose monitoring, cardiometabolic testing, infectious disease testing, drug-of-abuse testing, fertility and pregnancy testing, and others. Cardiometabolic testing kits are expected to grow significantly due to the rising prevalence of CVD and diabetes. Glucose monitors are critical for diabetes management, while drug-of-abuse and pregnancy testing kits gain traction due to their ease of use and rapid results. By distribution, the market includes various channels, with accessibility driving adoption across segments.

Geographical Outlook

North America is poised to dominate the rapid diagnostic kits market, driven by high disease prevalence, robust healthcare infrastructure, and widespread awareness campaigns. Organizations like the American Heart Association (AHA) and American Medical Association (AMA) promote preventive health measures, boosting kit adoption. The Asia-Pacific region, however, is projected to grow at the fastest rate, fueled by the rising burden of non-communicable diseases (NCDs) like CVD, diabetes, and cancer. Increasing government healthcare investments and growing awareness support market expansion, though high costs and lower adoption rates in some areas pose challenges.

The rapid diagnostic kits market is set for growth, driven by the rising incidence of chronic diseases and increasing demand for accessible, user-friendly diagnostic tools. Cardiometabolic and glucose monitoring kits lead due to their relevance in managing prevalent conditions. North America holds the largest market share, while Asia-Pacific promises rapid growth. Despite technological advancements, accuracy issues, high costs, and competition from alternative diagnostics limit potential. Industry stakeholders must focus on improving kit reliability and affordability to capitalize on global health trends.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Technology

  • Lateral Flow Assay
  • Agglutination
  • Others

By Application

  • Glucose Monitoring
  • Cardiometabolic Testing
  • Infectious Disease Testing
  • Drugs-of-Abuse Testing
  • Fertility & Pregnancy Testing
  • Others

By End-User

  • Hospitals & Clinics
  • Diagnostics Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Lateral Flow Assay
  • 5.3. Agglutination
  • 5.4. Others

6. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Glucose Monitoring
  • 6.3. Cardiometabolic Testing
  • 6.4. Infectious Disease Testing
  • 6.5. Drugs-ON-Abuse Testing
  • 6.6. Fertility & Pregnancy Testing
  • 6.7. Others

7. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Diagnostics Centers
  • 7.4. Others

8. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Taiwan
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Creative Diagnostics
  • 10.2. Abbott Laboratories
  • 10.3. NanoRepro AG
  • 10.4. Atlas Medical UK
  • 10.5. Coris BioConcept
  • 10.6. Roche Diagnostics
  • 10.7. SD Biosensor
  • 10.8. ACON Laboratories Inc.
  • 10.9. Alfa Scientific Designs Inc.
  • 10.10. AdvaCare Pharma

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations